NASDAQ-GM · traded in Congress
AtriCure, ATRC
$58.10 -1.02 (-1.73%) Sep 17, 2026
Market value$3.0B
P/E ratio-
Analyst target$55.00
52-week range-
Avg volume898,901
Dividend yieldN/A
Chart
Congress trades in ATRC
Members of Congress disclosed 2 transactions in ATRC in the filings we have processed.
| Traded | Member | Type | Amount | Filed |
|---|---|---|---|---|
| 08/20/2026 | Gilbert Cisneros CA31 | Purchase | $1,001 - $15,000 | 9/10/2026 filing |
| 03/03/2026 | Gilbert Cisneros CA31 | Purchase | $1,001 - $15,000 | 4/7/2026 filing |
Disclosed under the STOCK Act. Amounts are the ranges the law requires, filings can lag a trade by up to 45 days, and a disclosure is not evidence of wrongdoing. All congressional trades ›
Other companies
Price and key figures from Nasdaq's public quote data, refreshed through the day; the chart is live from TradingView. Congressional trades parsed from official House filings. Market information, not investment advice.